SE9502926D0 - Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it - Google Patents

Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it

Info

Publication number
SE9502926D0
SE9502926D0 SE9502926A SE9502926A SE9502926D0 SE 9502926 D0 SE9502926 D0 SE 9502926D0 SE 9502926 A SE9502926 A SE 9502926A SE 9502926 A SE9502926 A SE 9502926A SE 9502926 D0 SE9502926 D0 SE 9502926D0
Authority
SE
Sweden
Prior art keywords
anergy
hiv
vaccines
peptides
drugs
Prior art date
Application number
SE9502926A
Other languages
English (en)
Inventor
Jonas Blomberg
Ruediger Pipkorn
Original Assignee
Replico Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Replico Medical Ab filed Critical Replico Medical Ab
Priority to SE9502926A priority Critical patent/SE9502926D0/sv
Publication of SE9502926D0 publication Critical patent/SE9502926D0/sv

Links

SE9502926A 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it SE9502926D0 (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE9502926A SE9502926D0 (sv) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9502926A SE9502926D0 (sv) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it

Publications (1)

Publication Number Publication Date
SE9502926D0 true SE9502926D0 (sv) 1995-08-24

Family

ID=20399260

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502926A SE9502926D0 (sv) 1995-08-24 1995-08-24 Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it

Country Status (1)

Country Link
SE (1) SE9502926D0 (sv)

Similar Documents

Publication Publication Date Title
ZA964694B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection.
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
ZA964680B (en) Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.
NL7702784A (nl) Werkwijze voor het zuiveren en isoleren van he- patitisvirus ten gebruike bij de bereiding van een vaccin.
GB2255093A (en) Hiv-1 core protein fragments
IL107262A0 (en) Oral vaccines comprising multiple emulsions and methods of preparation
MX9202781A (es) Vacuna y metodo de tratamiento para virus de inmunodeficiencia humana.
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
NZ239281A (en) Antigenic hiv conjugate, vaccine and pharmaceutical composition
EP0868196A4 (en) SYNTHETIC VACCINE TO PROTECT AGAINST INFECTION BY THE HUMANE IMMUNDEFIZIENZ VIRUS
IT1318365B1 (it) Dispositivo di protezione per l'ago per siringa ad uso medicale.
EP0437729A3 (en) New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses
SE9502926D0 (sv) Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it
RU98111152A (ru) Применение активного вещества флупиртина или его фармакологически приемлемых солей в качестве лекарственного средства для профилактики и лечения заболеваний, ассоциированных с повреждением клеточной системы гемопоэза
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
DE69130571D1 (de) Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
AU2065488A (en) The preparation of antigens of human immunodeficiency virus type 1, and the use thereof as diagnostic and therapeutic agent
BR0112874A (pt) Uso de fribratos para a preparação de um medicamento útil no tratamento de falha de coração congestiva
Highleyman Major vaccine trials begin
RU93016671A (ru) Иммуномодулятор
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
FR2735694B1 (fr) Le cladinose a titre de medicament et les compositions pharmaceutiques les renfermant